SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-182430
Filing Date
2023-07-06
Accepted
2023-07-06 08:08:59
Documents
17
Period of Report
2023-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d486699d8k.htm   iXBRL 8-K 39287
2 EX-3.1 d486699dex31.htm EX-3.1 14427
3 EX-3.2 d486699dex32.htm EX-3.2 75890
4 EX-10.1 d486699dex101.htm EX-10.1 48744
5 EX-10.2 d486699dex102.htm EX-10.2 142841
6 EX-10.3 d486699dex103.htm EX-10.3 37385
  Complete submission text file 0001193125-23-182430.txt   567056

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20230703.xsd EX-101.SCH 2864
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20230703_lab.xml EX-101.LAB 17979
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20230703_pre.xml EX-101.PRE 11267
11 EXTRACTED XBRL INSTANCE DOCUMENT d486699d8k_htm.xml XML 3432
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 231072138
SIC: 3841 Surgical & Medical Instruments & Apparatus